| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.042 | 0.4 |